Exocrine Pancreatic Insufficiency Overview
Learn About Exocrine Pancreatic Insufficiency
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
University Of Pittsburgh Physicians, Department Of Medicine, Division Of Gastroenterology
David Whitcomb, MD, PhD, specializes in gastroenterology and is board-certified in internal medicine by the American Board of Internal Medicine. He is affiliated with UPMC Presbyterian. Dr. Whitcomb completed his fellowship and residencies at the Duke University School of Medicine and medical degree at Ohio State University College of Medicine. Dr. Whitcomb is rated as an Elite provider by MediFind in the treatment of Exocrine Pancreatic Insufficiency. His top areas of expertise are Hereditary Pancreatitis, Chronic Pancreatitis, Acute Pancreatitis, Pancreaticoduodenectomy, and Pancreatectomy.
Cleveland Clinic Children's Outpatient Center
Seth Corey is a Pediatrics provider in Cleveland, Ohio. Dr. Corey has been practicing medicine for over 47 years and is rated as an Elite provider by MediFind in the treatment of Exocrine Pancreatic Insufficiency. His top areas of expertise are Exocrine Pancreatic Insufficiency, Infantile Neutropenia, Anemia, and Paroxysmal Nocturnal Hemoglobinuria (PNH).
Asbjorn Drewes practices in Aalborg, Denmark. Drewes is rated as an Elite expert by MediFind in the treatment of Exocrine Pancreatic Insufficiency. Their top areas of expertise are Chronic Pancreatitis, Hereditary Pancreatitis, Exocrine Pancreatic Insufficiency, Lithotripsy, and Hepato-Pancreato-Biliary Surgery.
Background: A prospective cohort of Inherited Bone Marrow Failure Syndrome (IBMFS) will provide new information regarding cancer rates and types in these disorders. Pathogenic variant(s) in IBMFS genes are relevant to carcinogenesis in sporadic cancers. Patients with IBMFS who develop cancer differ in their genetic and/or environmental features from patients with IBMFS who do not develop cancer. These cancer-...
Summary: The purpose of this research is to determine if the use of RELiZORB™ improves nutrition tolerance and helps critically ill patients meet their nutrition goals. RELiZORB™ is a digestive enzyme cartridge that contains lipase and works as a pancreatic enzyme replacement. It promotes breaking down fat and helps the body absorb it. The device connects with tube feedings to help the body with digestion....


